The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible loan notes to raise circa US$5.0m

1 Oct 2014 07:00

RNS Number : 0791T
Arria NLG PLC
01 October 2014
 



1 October 2014

Arria NLG plc

 ("Arria" or the "Company")

 

Issue of convertible loan notes to raise circa US$5.0 million

 

Arria NLG plc (AIM: NLG), a leader in the development and deployment of Natural Language Generation ("NLG") technologies, announces that it has raised approximately US$5.0 million through the issue of unsecured convertible loan notes (the "Notes") to an existing shareholder of the Company.

 

On 30 September 2014 Arria entered into a subscription agreement with The Ikonic Fund SAC Limited ("Ikonic"), pursuant to which Ikonic has agreed to subscribe for the Notes in three tranches, by the following dates: (i) £1.232 million (circa US$2 million) of the Notes by 31 December 2014; (ii) £1.232 million (circa US$2 million) of the Notes by 31 December 2015; and (iii) £0.616 million (circa US$1 million) of the Notes by 31 March 2016. The issue of the Notes to Ikonic will raise a total of £3.08 million (circa US$5.0 million) for the Company.

 

Ikonic, which is an investment fund affiliated with a real estate, insurance and banking group based in the Bahamas, currently holds 3,125,000 ordinary shares in the capital of the Company (the "Ordinary Shares") representing approximately 3.06 per cent. of the issued share capital of the Company, together with listed warrants to subscribe for an additional 3,125,000 Ordinary Shares, exercisable until 30 September 2017 at £1.33 per Ordinary Share ("Warrants").

 

Once received, the funds raised by the issue of the Notes will be used to fund the Company's operations and expansion of its commercial activities, which are focussed primarily on the oil & gas and financial services sectors.

 

Under the terms of the subscription agreement, Ikonic has agreed that it (together with any parties to whom it is connected) will not acquire more than 25.0 per cent. of the issued ordinary share capital of the Company prior to 31 October 2019 (being the maturity date of the Notes), such percentage to be calculated on the assumption that Ikonic and any parties to whom it is connected have exercised all conversion rights attached to the Notes and Warrants. Ikonic shall be entitled to appoint an observer to receive Board papers and attend Board meetings of the Company.

 

Stuart Rogers, Chairman and Chief Executive of Arria NLG plc, commented:

 

"Since our listing on AIM in December 2013, Arria has made exciting progress with both our existing clients and new clients and we are in discussions with a number of parties in the oil & gas and financial services sectors about revenue earning contracts. It is now appropriate for the Company to raise additional funding to enable it to continue its commercial progress. The issue of the Notes to Ikonic is the start of this process and we are continuing our fundraising activities. As a result I anticipate that the Company will be raising additional equity or debt funding in the near future.

 

Terms of the Loan Notes

 

The Notes are constituted by a loan note instrument dated 30 September 2014 (the "Instrument") which creates £3,080,000 (circa US$5,000,000) of Notes.

 

The Notes have a maturity date of 31 October 2019 (the "Maturity Date") and accrue interest at a rate of five per cent. above the Bank of England base rate as at 31 October of each year (the "Interest Payment"). Interest Payments begin on 31 October 2015 and will be payable annually on 31 October each calendar year thereafter (the "Interest Payment Date") until the Maturity Date.

 

The Company can redeem the Notes, without penalty or fee, at any time upon 10 business days' notice to the holders of the Notes (the "Noteholders"). The Noteholders will be entitled to convert the Notes and any accrued but unpaid interest into new Ordinary Shares at a price of £0.40 per share (subject to adjustment in certain customary circumstances) during the first 10 business days of each calendar year and also following receipt of notice that the Company intends to redeem the Notes.

 

The Interest Payments shall be calculated with interest accruing on the principal amount of the Notes outstanding, compounding on an annual basis. Interest payments can be paid (and Noteholders can require them to be paid) through the issue of payment in kind notes of equal nominal value in full or partial satisfaction of any interest that has accrued but which remains unpaid in respect of the Notes up to that date.

 

For further information, please visit www.arria.com or contact:

 

Arria NLG plc

Stuart Rogers, Chairman and Chief Executive

 

Tel +44 (0) 20 7100 4540

Allenby Capital Limited, Nominated Adviser and Joint Broker

Jeremy Porter

Nick Naylor

James Reeve

 

Tel: +44 (0)20 3328 5656

 

Westhouse Securities, Joint Broker

Antonio Bossi

Robert Finlay

 

Tel: +44 (0) 20 7601 6100

Walbrook, Financial PR and IR

Bob Huxford

Guy McDougall

 Tel: 44 (0)20 7933 8792

arria@walbrookpr.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUPWBUPCGQU
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.